Prof. Dr. Reinhard Schinzel

vasopharm GmbH
Friedrich-Bergius-Ring 15
D-97076 Würzburg / Germany
Fon: +49 (0)931-359099-115
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Interests
vasopharm has developed VAS203, a cofactor-derived Nitric Oxide Synthase Inhibitor particularly for the treatment of the consequences of closed head injuries. The inhibitor is currently tested in clinical studies. Furthermore, vasopharm is interested in new approaches to measure NO bioavailability in blood, in particular in platelets using the phosphorylation state of a specific platelet protein (VASP).


Selected Recent Publications